Pricing Log in Create free account

Boundless Bio, Inc. (BOLD) vs Telomir Pharmaceuticals, Inc. (TELO)

Boundless Bio, Inc. and Telomir Pharmaceuticals, Inc. are both Biotechnology companies. Boundless Bio, Inc. and Telomir Pharmaceuticals, Inc. are of similar size ($57.5M and $54.8M). Across the 9 metrics below, Boundless Bio, Inc. leads on 5 and Telomir Pharmaceuticals, Inc. on 4.

Valuation

Metric BOLD TELO Biotechnology median
P/E n/m n/m 10.60
P/S n/m n/m 9.40
P/B 0.83 8.82 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m n/m 0.66
EV/Sales n/m n/m 9.02
Earnings yield (116.73%) (124.66%) (32.88%)
Free cash flow yield (103.14%) (11.07%) (23.13%)

Profitability

Metric BOLD TELO Biotechnology median
Gross margin — — 68.51%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (67.86%) (1,885.50%) (51.96%)
Return on assets (50.56%) (1,678.31%) (46.06%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric BOLD TELO Biotechnology median
Revenue growth (TTM) — — 6.76%
EPS growth (last fiscal year) 32.47% 41.07% 29.88%
Revenue growth, 5-year CAGR — — 9.75%
Net income growth, 5-year CAGR — — 0.00%

Health

Metric BOLD TELO Biotechnology median
Debt to equity 0.00 0.03 0.00
Current ratio 9.48 16.14 4.97
Net debt to EBITDA 0.99 0.69 1.01

Dividend

Metric BOLD TELO Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric BOLD TELO Biotechnology median
Market cap 54.83m 57.48m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack